novavax
said
tuesday
received
permission
food
drug
administration
proceed
pharmacokinetic
dose
response
studies
estrasorb.estrasorb
proprietary
topical
micellar
nanoparticle
cream
containing
encapsulated
natural
human
estrogen
symptomatic
menopausal
women
company
said.estrasorb
series
encapsulated
topical
drug
product
candidates
using
novavax
proprietary
delivery
technology
enter
pharmacokinetic
dose
response
studies
company
said.in
study
approved
today
company
said
initial
group
10
women
receive
7.5
mg
estrogen
daily
weeks.novavax
said
received
permission
dose
additional
patient
groups
higher
lower
doses
study
